Antibiotic-Free Selection in Biotherapeutics: Now and Forever
Open accessThe DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Abstract
The continuously improving sophistication of molecular engineering techniques gives access to novel classes of bio-therapeutics and new challenges for their production in full respect of the strengthening regulations. Among these biologic agents are DNA based vaccines or gene therapy products and to a lesser extent genetically engineered live vaccines or delivery vehicles. The use of antibiotic-based selection, frequently associated with genetic manipulation of microorganism is currently undergoing a profound metamorphosis with the implementation and diversification of alternative selection means. This short review will present examples of alternatives to antibiotic selection and their context of application to highlight their ineluctable invasion of the bio-therapeutic world.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The global health agencies (FDA, EMA, WHO) also discourage the use of β-lactams (i.e., ampicillin, penicillin) and streptomycin resistance genes in plasmids for gene therapy [227].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [227]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782 · cited 1×
“To produce a recombinant protein, a way to avoid the antibiotic resistance marker is to integrate the gene of interest into bacterial chromosome [83].”
BackgroundMolecular mechanisms of antibiotic resistance
Blair, J. M. A., Webber, M. A., Baylay, A. J., Ogbolu, D. O., & Piddock, L. J. V. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3380 · Cited by 4,092 · cited 1×
“It becomes clear that antibiotic-resistant bacteria are causing a global health crisis and that mechanisms behind acquisition of resistance are more and more documented [8].”
BackgroundHerrero, M., de Lorenzo, V, & Timmis, K. N. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.11.6557-6567.1990 · Cited by 1,586 · cited 1×
“[54]”
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
Wiedenbeck, J., & Cohan, F. M. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00292.x · Cited by 663 · cited 1×
“More recently, acquisition of the virulence factors that distinguish Salmonella from Escherichia coli has been clearly shown as the result of horizontal gene transfer [13].”
BackgroundMini-F plasmid genes that couple host cell division to plasmid proliferation.
Ogura, T., & Hiraga, S. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.15.4784 · Cited by 575 · cited 2×
“These authors also put in evidence that the combination SopA, SopB and SopC was not sufficient for a complete stabilization of mini-F plasmid, and thus identified the additional element ccd (control of cell death) region that seemed crucial to control cell division when copy number carrying ccd segment decreases [18].”
BackgroundPenicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569 · cited 1×
“As early as in 1965, Datta and Kontomichalou [11] showed the widespread transfer of penicillin resistance across Enterobacteriaceae.”
BackgroundSummers, D. K., & Sherratt, D. J. (1984) · Cell · doi:10.1016/0092-8674(84)90060-6 · Cited by 452 · cited 1×
“Concerning plasmid maintenance, it has been shown that factors reducing multimerization of plasmid could increase plasmid stability [24].”
BackgroundNikol, S., Baumgartner, I., Van Belle, E., Diehm, C., Visoná, A., Capogrossi, M. C., Ferreira-Maldent, N., Gallino, A., Graham Wyatt, M., Dinesh Wijesinghe, L., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.33 · Cited by 333 · cited 1×
“First human phase I and II clinical trials using plasmid pCOR encoding fibroblast growth factor 1 have suggested an improvement of perfusion and an increase in amputation free survival in patients with critical limb ischemia [98].”
BackgroundA robust system for production of minicircle DNA vectors
Kay, M. A., He, C.-Y., & Chen, Z.-Y. (2010) · Nature Biotechnology · doi:10.1038/nbt.1708 · Cited by 329 · cited 1×
“Cre recombinase [87] or ΦC31 integrase [65,68].”
Research works printed but not linked: 1
- WHO (2005, January 24–28). Guidelines for assuring the quality of non clinical safety evaluation of DNA vaccines. Proceedings of the 56th Meeting of the WHO Expert Committee on Biological Standardization, Geneva, Switzerland.
Cited by
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
'Deadman' and 'Passcode' microbial kill switches for bacterial containment
Chan, C. T. Y., Lee, J. W., Cameron, D. E., Bashor, C. J., & Collins, J. J. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.1979 · Cited by 399
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
Cid, R., & Bolívar, J. (2021) · Biomolecules · doi:10.3390/biom11081072 · Cited by 176
Safety Aspects of Genetically Modified Lactic Acid Bacteria
Plavec, T. V., & Berlec, A. (2020) · Microorganisms · doi:10.3390/microorganisms8020297 · Cited by 156
“According to their mechanisms of action, these systems can be based on auxotrophic, nonantibiotic dominant and complementary markers, post-segregational killing, RNA interference, or de-repression of an essential gene or minicircle [88].”
BackgroundDNA Vaccines: Their Formulations, Engineering and Delivery
Kozak, M., & Hu, J. (2024) · Vaccines · doi:10.3390/vaccines12010071 · Cited by 115
“This has led to a concern about antibiotic resistance as a possible adverse effect of DNA vaccination should the antibiotic resistance gene be integrated [203].”
Background
Metadata
- Authors
- Mignon, C., Sodoyer, R., & Werle, B.
- Affiliations
- BIOASTER (FR)
- Corresponding author
- Sodoyer, Régis
- ORCID
- Mignon, Charlotte
- Venue
- Pathogens
- Publisher
- MDPI AG
- Published
- 2015-04-03
- Volume
- 4
- Issue
- 2
- Pages
- 157-181
- ISSN
- 2076-0817 (ISSN-L)
- PMC
- PMC4493468
- OpenAlex
- W2057140623
- Cited by
- 87
- References
- 110
- Citations by year
- 2026: 10 · 2025: 5 · 2024: 9 · 2023: 6 · 2022: 14 · 2021: 12 · 2020: 7 · 2019: 7 · 2018: 7 · 2017: 3 · 2016: 5 · 2015: 2
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
- Keywords
- antibiotic-free selection, biopharmaceutical manufacturing, DNA vaccine, gene therapy products, delivery vehicles, molecular engineering
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.